PPL vs TRVI · P/E 22, rev $9.04B vs $2.32B cap
PPL Corporation (PPL) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
TRVI does not have a complete income-statement cache yet.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the PPL and TRVI stock pages for the full models.
Not investment advice.